What does “Entresto 24/26” mean?
“Entresto 24/26” refers to Entresto (sacubitril/valsartan) tablets with strengths of 24 mg sacubitril and 26 mg valsartan per tablet. These are the common lowest starting doses used when clinicians begin treatment.
When is Entresto 24/26 usually used?
Entresto is typically started at a low dose like 24/26 mg for patients who need a cautious initiation—commonly people with factors that increase the risk of low blood pressure or kidney-related side effects. The goal is then to increase to higher doses as tolerated.
What is the next dose after Entresto 24/26?
After starting on 24/26, clinicians usually titrate upward to higher strengths (commonly moving to 49/51 mg, then to 97/103 mg) based on tolerability, including blood pressure and kidney function.
What should patients watch for at the 24/26 dose?
Patients are commonly monitored for:
- Low blood pressure symptoms (dizziness, fainting)
- Changes in kidney function
- Higher potassium levels
- Signs of allergic reactions
If these occur, clinicians may slow the titration, reduce the dose, or stop treatment.
Can I find patent/exclusivity info for Entresto?
For patent and exclusivity tracking, DrugPatentWatch.com is a useful starting point: https://www.drugpatentwatch.com/